UBS Group
AMTI

UBS Group’s Applied Molecular Transport Inc. Common Stock AMTI Stock Holding History

UBS Group’s Portfolio AMTI Stock Details AMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,233
Closed -$576 – 10204
2023
Q2 		$576 Sell
2,233
-8,150
-78% -$2.31K ﹤0.01% 8173
2023
Q1 		$3.32K Sell
10,383
-1,844
-15% -$962 ﹤0.01% 8341
2022
Q4 		$5.13K Sell
12,227
-1,279,779
-99% -$1.29M ﹤0.01% 9218
2022
Q3 		$1.26M Buy
+1,292,006
New +$2.28M ﹤0.01% 3555
2022
Q1 		– Sell
-7,539
Closed -$106K – 11183
2021
Q4 		$106K Sell
7,539
-33,946
-82% -$669K ﹤0.01% 6266
2021
Q3 		$1.07M Buy
41,485
+40,136
+2,975% +$1.27M ﹤0.01% 4143
2021
Q2 		$62K Sell
1,349
-3,946
-75% -$187K ﹤0.01% 6246
2021
Q1 		$233K Buy
5,295
+5,115
+2,842% +$249K ﹤0.01% 5374
2020
Q4 		$6K Buy
+180
New +$5.71K ﹤0.01% 7789
2020
Q3 		– Sell
-919
Closed -$23K – 8541
2020
Q2 		$23K Buy
+919
New +$23.2K ﹤0.01% 6476

Other funds holding AMTI

ECG
EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return
FFVM
Founders Fund V Management San Francisco, California $2.16M AUM 77.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FFVM
Founders Fund VI Management San Francisco, California $45.8K AUM 58.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

UBS Group's AMTI Position: Q3 2023 in Review

UBS Group sold out of Applied Molecular Transport Inc. Common Stock (AMTI) in Q3 2023, closing a stake of 2,233 shares — an estimated $576 sold.

UBS Group first reported a position in AMTI in Q2 2020 and held it in 10 quarters. The position peaked at $1.26M in Q3 2022. 27 funds tracked by Wall St. Rank hold AMTI as of Q3 2023.

  • UBS Group reported no remaining Applied Molecular Transport Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • UBS Group sold 2,233 Applied Molecular Transport Inc. Common Stock shares in Q3 2023, an estimated $576.
  • UBS Group first reported a position in Applied Molecular Transport Inc. Common Stock in Q2 2020 and held it in 10 quarters.
  • UBS Group's Applied Molecular Transport Inc. Common Stock position peaked at $1.26M in Q3 2022.
  • 27 funds tracked by Wall St. Rank held Applied Molecular Transport Inc. Common Stock as of Q3 2023.

Based on UBS Group's 13F filing for Q3 2023, filed 9 Nov 2023.